Skip to main content
. 2017 Oct 12;12(10):e0186013. doi: 10.1371/journal.pone.0186013

Fig 1. Bioavailability of ticagrelor and AR-C124910XX over time in patients with STEMI and NSTEMI.

Fig 1

Plasma concentrations of (A) ticagrelor and (B) AR-C124910XX during the first 6 h after oral administration of a 180 mg ticagrelor loading dose in patients with STEMI and NSTEMI. NSTEMI: non-ST-elevation myocardial infarction, STEMI: ST-elevation myocardial infarction.